| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $737M | $347M | — | 112.5% | — |
| Op. Income | $242M | $335M | — | -27.7% | — |
| Gross Margin | 33.4% | 18.8% | — | 14.5pp | — |
| Net Margin | 17.6% | 64.1% | — | -46.5pp | — |
| EPS (Diluted) | $0.33 | $0.56 | — | -41.1% | — |
| Free Cash Flow | $42M | $3M | — | 1265.2% | — |
| Item | Amount |
|---|---|
| REVENUE | $737M |
| Cost of Revenue | $491M |
| GROSS PROFIT | $246M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $32M |
| Other Expenses | -$29M |
| Operating Expenses | $3M |
| Cost & Expenses | $495M |
| OPERATING INCOME | $242M |
| Interest Income | $5M |
| Interest Expense | $17M |
| Other Income/Expenses | $19M |
| INCOME BEFORE TAX | $261M |
| Income Tax Expense | $131M |
| Net Income from Continuing Ops | $130M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $130M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $130M |
| D&A | $158M |
| EBIT | $279M |
| EBITDA | $437M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $737M |
| Cost of Revenue | $491M |
| GROSS PROFIT | $246M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $32M |
| Other Expenses | -$29M |
| Operating Expenses | $3M |
| Cost & Expenses | $495M |
| OPERATING INCOME | $242M |
| Interest Income | $5M |
| Interest Expense | $17M |
| Other Income/Expenses | $19M |
| INCOME BEFORE TAX | $261M |
| Income Tax Expense | $131M |
| Net Income from Continuing Ops | $130M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $130M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $130M |
| D&A | $158M |
| EBIT | $279M |
| EBITDA | $437M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $130M |
| Depreciation & Amortization | $158M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$22M |
| Other Non-Cash Items | $51M |
| Change in Working Capital | -$130M |
| OPERATING CASH FLOW | $188M |
| Capital Expenditure | -$145M |
| Acquisitions (Net) | -$101.8K |
| Purchases of Investments | -$43M |
| Sales/Maturities of Investments | $785.3K |
| Other Investing Activities | -$3M |
| NET CASH FROM INVESTING | -$191M |
| Net Debt Issuance | -$40M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $4.0K |
| Other Financing Activities | -$16M |
| NET CASH FROM FINANCING | -$39M |
| FREE CASH FLOW | $42M |
| Net Change in Cash | -$43M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $568M |
| Short-Term Investments | $0 |
| Net Receivables | $378M |
| Inventory | $199M |
| Other Current Assets | $16M |
| TOTAL CURRENT ASSETS | $1.2B |
| PP&E (Net) | $4.7B |
| Goodwill | $72M |
| Intangible Assets | $7M |
| Long-Term Investments | $131M |
| Tax Assets | $66M |
| Other Non-Current Assets | $89M |
| TOTAL NON-CURRENT ASSETS | $5.1B |
| TOTAL ASSETS | $6.2B |
| Account Payables | $342M |
| Short-Term Debt | $498M |
| Deferred Revenue | $52M |
| Other Current Liabilities | $213M |
| TOTAL CURRENT LIABILITIES | $1.2B |
| Long-Term Debt | $565M |
| Deferred Revenue NC | $265M |
| Deferred Tax Liabilities | $375M |
| Other Non-Current Liabilities | $527M |
| TOTAL NON-CURRENT LIABILITIES | $1.8B |
| TOTAL LIABILITIES | $3.0B |
| Common Stock | $2.7B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $460M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $102M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.2B |
| Minority Interest | $0 |
| TOTAL EQUITY | $3.2B |
| TOTAL LIABILITIES & EQUITY | $6.2B |
| Total Debt | $1.1B |
| Net Debt | $524M |
